Resources Blog Biointron Receives "Top 100 Chinese Life Science Service Companies of 2023" Award!

Biointron Receives "Top 100 Chinese Life Science Service Companies of 2023" Award!

Biointron 2023-12-09 Read time: 2 mins
Biointron Receives 'Top 100 Chinese Life Science Service Companies of 2023' Award!

The 15th Chinese Healthcare Summit of Entrepreneurs, Scientists, and Investors (CHSESI) was held in Hangzhou, China.

In order to better promote the development of the life sciences sector and advance the upgrade of the innovation ecosystem, industry expert judges spent three months conducting a comprehensive survey. This research assessed Chinese life science service companies based on three dimensions: brand recognition, cost-effectiveness of cooperation, and service satisfaction. The outcome of this meticulous evaluation was the grand unveiling of the "Top 100 Chinese Life Science Service Companies" list at the conference.

Specializing in antibody expression and CRO services for antibody discovery and optimization, Biointron successfully stood out from numerous excellent and highly competitive life science service companies in China. As a result, we have been honored with the award of "Top 100 Chinese Life Science Service Companies of 2023."

Being listed among the top companies represents the industry's recognition of Biointron's capabilities in antibody expression and CRO services for antibody discovery. In the future, Biointron will continue to leverage its innovative and scientific technical advantages. Remaining steadfast in its mission as an "Accelerating Antibody Discovery", we are committed to becoming an outstanding antibody CRO in the global antibody industry, providing one-stop antibody discovery services.

Subscribe to our Blog

Recent Blog

Computational antibody methods schematic. DOI: 10.1093/bib/bbz095The development of therapeutic antibodies has been significantly enhanced by advancements in computational methods and artificial intelligence (AI). These technologies have streamlined the antibody discovery process, improving the abil

May 27, 2024

Welcometo Antibody Basics by Biointron,Part 8. In this episode, we’ll talk about therapeutics targeting cancer.What is cancer immunotherapy?Cancer immunotherapy leverages the body's immune system to fight cancer more selectively and effectively than traditional methods such as chemotherapy

May 24, 2024

The generation of an immune response to a vaccine. DOI: 10.1038/s41577-020-00479-7Vaccination is one of the most effective tools in preventing infectious diseases. At its core, the success of a vaccine hinges on its ability to induce a robust and lasting antibody response against a specific pathogen

May 22, 2024

Innovation orientation and goals for transforming CAR-T cell engineering. DOI: 10.1186/s13045-020-00910-5Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary cancer treatment in which engineered CARs redirect lymphocytes, typically T cells, to recognize and destroy cells expressing a sp

May 20, 2024

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.